Our publications
Measurement properties of the German version of the Cambridge examination for mental disorders of older people with Down syndrome and others with intellectual disabilities (CAMDEX-DS)
Sandra V. Loosli, Lennart C. Neumann, Elisabeth Wlasich, Catharina Prix, Laura Koll, Endy Weidinger, Jonathan Vöglein, Olivia Wagemann, Adrian Danek, Georg Nübling & Johannes Levin
Journal of Intellectual & Developmental Disability, February 2024
Common mental health disorders and cognitive decline in a longitudinal Down syndrome cohort
Idris M, Saini F, Pape SE, Baksh RA, Cahart MS, Strydom A
Cambridge University Press November 2023
Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer’s disease in adults with Down syndrome
Mgaieth F, Baksh RA, Startin CM, Hamburg S, Hithersay R, Pape S, Zetterberg H, Ashton NJ, Tamayo-Elizalde M, Saini F, Idris M, Consortium TL, Strydom A
The Journal of the Alzheimer’s Association April 2023
The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease
T. Rujeedawa, E. Carrillo Félez, I. C. H. Clare, J. Fortea, A. Strydom, AS. Rebillat, A. Coppus, J. Levin, S. H. Zaman
Journal of Clinical Medicine, October 2021
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study
M. Carmona-Iragui, D. Alcolea, I. Barroeta, L. Videla, L. Muñoz, K. L Van Pelt, F. A Schmitt, D. D Lightner, L. M Koehl, G. Jicha, S. Sacco, C. Mircher, S. E Pape, R. Hithersay, I. C H Clare, A. J Holland, G. Nübling, J. Levin, S. H Zaman, A. Strydom, A-S Rebillat, E. Head, R. Blesa, A. Lleó, J. Fortea
The Lancet, Neurology, August 2021
Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease
Nübling, G. S., Prix, C., Brendel, M., Beyer, L., Wlasich, E., Loosli, S. V., Barthel, H., Sabri, O., Bartenstein, P., Vöglein, J., Danek, A., Rominger, A., Edbauer, D., Haass, C., Levin, J.
Neurobiology of Aging, July 2021
Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer’s disease
J. Aschenbrenner, R. A. Baksh, B. Benejam, J. A. Beresford-Webb, A. Coppus, J. Fortea, B. L. Handen, S. Hartley, E. Head, J. Jaeger, J. Levin, S. V. Loosli, A.-S. Rebillat, S. Sacco, F. A. Schmitt, K. E. Thurlow, S. Zaman, J. Hassenstab, A. Strydom
Alzheimer’s Dementia, 19 April 2021
Prognostic performance and longitudinal changes in plasma Neurofilament light levels in adults with Down syndrome: a multicentre longitudinal study
M. Carmona-Iragui, D. Alcolea, I. Barroeta, L. Videla, L. Muñoz, K. Van Pelt, F. Schmitt, D. Lightner, L. Koehl, G. Jicha, S. Sacco, C. Mircher, S. Pape, R. Hithersay, I. Clare, A. Holland, G. Nübling, J. Levin, S. Zaman, A. Strydom A.-S. Rebillat, E. Head, R. Blesa, A. Lleó, J. Fortea
The Lancet Neurology, 16 Apr 2021
Opportunities, barriers, and recommendations in Down syndrome research
Hendrix James A, Amon Angelika, Abbeduto Leonard, Agiovlasitis Stamatis, Alsaied Tareke, Anderson Heather A., Bain Lisa J., Baumer Nicole, Bhattacharyya Anitai, Bogunovic Dusan, Botteron Kelly N., Capone George, Chandan Priya, Chase Isabelle, Chicoine Brian, Cieuta-Walti Cécile, DeRuisseau Lara R., Durand Sophie, Esbensen Anna, Fortea Juan, Giménez Sandra, Granholm Ann-Charlotte, Mattie Laura J., Head Elizabeth, Hillerstrom Hampus, Jacola Lisa M., Janicki Matthew P., Jasien Joan M., Kamer Angela R., Kent Raymond D., Khor Bernard, Lawrence Jeanne B., Lemonnier Catherine, Lewanda Amy Feldman, Mobley William, Moore Paul E., Nelson Linda Pollak, Oreskovic Nicolas M., Osorio Ricardo S., Patterson David, Rasmussen Sonja A., Reeves Roger H, Roizen Nancy, Santoro Stephanie, Sherman Stephanie L., Talib Nasreen, Tapia Ignacio E., Walsh Kyle M., Warren Steven F., White A. Nicole, Wong G. William, Yi, John S
Translational Science of Rare Diseases, 15 April 2021
Kognition bei Down-Syndrom: Entwicklung über die Lebensspanne und neuropsychologische Diagnostik im Erwachsenenalter :
Cognition in Down’s Syndrome: Development across the Life Span and Neuropsychological Assessment in Adults
Loosli, S.V., Schmidt, L., Nübling, G., Wlasich, E., Prix, C., Danek, A., Levin, J.
Fortschritte der Neurologie – Psychiatrie, January 2021
The AT(N) framework for Alzheimer’s disease in adults with Down syndrome
S. Rafii, B. M. Ances, N. Schupf, S. J. Krinsky-McHale, M. Mapstone, W. Silverman, I. Lott, W. Klunk, E. Head, B. Christian, F. Lai, H. D. Rosas, S. Zaman, M. E. Petersen, A. Strydom, J. Fortea, B. Handen, S. O’Bryant
Alzheimer’s Dementia, Diagnosis, Assessment & Disease monitoring, July 2020
Further understanding the connection between Alzheimer’s disease and Down syndrome
M. Snyder, L. J. Bain, A. M. Brickman, M. C. Carrillo, A. J. Esbensen, J. M. Espinosa, F. Fernandez, J. Fortea, S. L. Hartley, E. Head, J. Hendrix, P. S. Kishnani, F. Lai, P. Lao, C. Lemere, W. Mobley, E. J. Mufson, H. Potter, S. H. Zaman, A-C Granholm, H. D. Rosas, A. Strydom, M. Sie Whitten, M. S. Rafii
Alzheimer’s Dementia, March 2020
Eine deutsche Fassung der CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down’s Syndrome and Others with Intellectual Disabilities).
Ein Diagnoseverfahren zur Erfassung von Demenz bei Menschen mit einem Down-Syndrom
Nübling, G., Loosli, S. V., Wlasich, E., Prix, C., Schönecker, S., Freudelsperger, L., Smrzka, N., Strydom, A. M., Zaman, S. H., Benejam, B., Missios, J., Meister, R., Danek, A., Levin, J
Zeitschrift für Geriatrie und Gerontologie, 53, 546-551 August 2019
Alzheimer’s disease in Down syndrome: An overlooked population for prevention trials.
A. Strydom, A. Coppus, R. Blesa, A. Danek, J. Fortea, J. Hardy, J. Levin, G. Nuebling, AS Rebillat, C. Ritchie, C. van Duijn, S. Zaman, H. Zetterberg
Alzheimers Dement (N Y). 13 Dec 2018
